I recently covered Carlsmed’s bold $100M IPO bid, noting how rare orthopedic offerings have been in recent years.
Now, Shoulder Innovations is stepping up to the plate with its own $100M filing. Whether SI, Carlsmed, or even Hinge Health emerge as breakout successes or cautionary tales remains to be seen—but it’s notable that these companies are testing the public markets in a sector where only Monogram (2023) and Treace (2021) have dared to go public in the last several years.
Shoulder Innovations, Inc. (SI), a medical device company specializing in shoulder arthroplasty, has initiated eff...
